These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 31653154

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Multiple gastrointestinal stromal tumors caused by a novel germline KIT gene mutation (Asp820Gly): a case report and literature review.
    Arima J, Hiramatsu M, Taniguchi K, Kobayashi T, Tsunematsu I, Kagota S, Sakane J, Suzuki Y, Hirota S.
    Gastric Cancer; 2020 Jul; 23(4):760-764. PubMed ID: 32146645
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [C-KIT in gastrointestinal stromal tumors and associated malignancies: A Study in a population with genetic isolation].
    Rodríguez-González D, Delgado-Plasencia L, Hernández-León C, Torres-Monzón E, Castro-Peraza ME, Cruz-Jurado J, Bravo-Gutiérrez A, Medina-Arana V.
    Gastroenterol Hepatol; 2015 Oct; 38(8):484-90. PubMed ID: 25843813
    [Abstract] [Full Text] [Related]

  • 30. The rs17084733 variant in the KIT 3' UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility.
    Ravegnini G, Serrano C, Simeon V, Sammarini G, Nannini M, Roversi E, Urbini M, Ferrè F, Ricci R, Tarantino G, Pantaleo MA, Hrelia P, Angelini S.
    Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prediction of KIT mutation in gastrointestinal stromal tumors by the immunoprofile of the tumor cells.
    Chou CC, Chou MJ, Tzen CY.
    J Formos Med Assoc; 2010 Jan; 109(1):25-31. PubMed ID: 20123583
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Stem cell factor-mediated wild-type KIT receptor activation is critical for gastrointestinal stromal tumor cell growth.
    Bai CG, Hou XW, Wang F, Qiu C, Zhu Y, Huang L, Zhao J, Xu JJ, Ma DL.
    World J Gastroenterol; 2012 Jun 21; 18(23):2929-37. PubMed ID: 22736916
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, Trent JC, von Mehren M, Wright JA, Schiffman JD, Raygada M, Pacak K, Meltzer PS, Miettinen MM, Stratakis C, Janeway KA, Helman LJ.
    JAMA Oncol; 2016 Jul 01; 2(7):922-8. PubMed ID: 27011036
    [Abstract] [Full Text] [Related]

  • 39. KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin.
    Lasota J, Kopczynski J, Sarlomo-Rikala M, Schneider-Stock R, Stachura T, Kordek R, Michal M, Boltze C, Roessner A, Stachura J, Miettinen M.
    Hum Pathol; 2003 Dec 01; 34(12):1306-12. PubMed ID: 14691917
    [Abstract] [Full Text] [Related]

  • 40. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY, Shi YQ, Zhou Y, Fu H, Zhao G.
    J Surg Oncol; 2008 Sep 01; 98(3):175-8. PubMed ID: 18618605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.